Effects of taurine on contractions of the porcine coronary artery

Pharmacological Reports

Volumn 61, Issue 4, 2009, Pages 681-689

  Liu, Yu ^a   Niu, Longgang ^a   Zhang, Wenjing ^a   Cui, Lijuan ^a   Zhang, Xuanping ^a   Liang, Yueqin ^a   Zhang, Mingsheng ^a  

^a SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Porcine coronary artery; Potassium channel opening; Taurine; Vasorelaxation

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 AMINOPYRIDINE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; BARIUM CHLORIDE; CALCIUM CHLORIDE; G PROTEIN COUPLED INWARDLY RECTIFYING POTASSIUM CHANNEL; HISTAMINE; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; POTASSIUM CHLORIDE; SEROTONIN; TAURINE; TETRYLAMMONIUM;

ANIMAL TISSUE; ARTERY CONSTRICTION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; DRUG MECHANISM; ENDOTHELIUM; HEART; NONHUMAN; SMOOTH MUSCLE TONE; SWINE; VASODILATATION;

EID: 70549096116     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/S1734-1140(09)70120-3     Document Type: Article

References (39)

1. Abebe W, Mozaffari MS: Effects of chronic taurine treatment on reactivity of the rat aorta. Amino Acids, 2000, 19, 615-623.
2. Abebe W, Mozaffari MS: Effect of taurine deficiency on adenosine receptor-mediated relaxation of the rat aorta. Vascul Pharmacol, 2003, 40, 219-228. (Pubitemid 38121220)
3. Abebe W, Mozaffari MS: Taurine depletion alters vascular reactivity in rats. Can J Physiol Pharmacol, 2003, 81, 903-909. (Pubitemid 37188268)
4. Bouckenooghe T, Remacle C, Reusens B: Is taurine a functional nutrient? Curr Opin Clin Nutr Metab Care, 2006, 9, 728-733.
5. Briel G, Gylfe E, Hellman B, Neuhoff V: Microdetermination of free amino acids in pancreatic islets isolated from obese-hyperglycemic mice. Acta Physiol Scand, 1972, 84, 247-253.
6. Chahine R, Feng J: Protective effects of taurine against reperfusion-induced arrhythmias in isolated ischemic rat heart. Arzneimittelforschung, 1998, 48, 360-364. (Pubitemid 28197846)
7. Cherif H, Reusens B, Dahri S, Remacle C, Hoet JJ: Stimulatory effects of taurine on insulin secretion by fetal rat islets cultured in vitro. J Endocrinol, 1996, 151, 501-506. (Pubitemid 26405598)
8. Feletou M, Vanhoutte PM: Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol, 2006, 26, 1215-1225.
9. Franconi F, Giotti A, Manzini S, Martini F, Stendardi I, Zilletti L: The effect of taurine on high potassium-and noradrenaline-induced contraction in rabbit ear artery. Br J Pharmacol, 1982, 75, 605-612. (Pubitemid 12189649)
10. Fujita T, Sato Y: The antihypertensive effect of taurine in DOCA-salt rats. J Hypertens, 1984, Suppl 2, S563-565.
11. Gurer H, Ozgunes H, Saygin E, Ercal N: Antioxidant effect of taurine against lead-induced oxidative stress. Arch Environ Contam Toxicol, 2001, 41, 397-402. (Pubitemid 33020158)
12. Hagar HH, El Etter E, Arafa M: Taurine attenuates hypertension and renal dysfunction induced by cyclosporine A in rats. Clin Exp Pharmacol Physiol, 2006, 33, 189-196.
13. Harada H, Kitazaki K, Tsujino T, Watari Y, Iwata S, Nonaka H, Hayashi T et al.: Oral taurine supplementation prevents the development of ethanol-induced hypertension in rats. Hypertens Res, 2000, 23, 277-284. (Pubitemid 30326259)
14. Harada H, Tsujino T, Watari Y, Nonaka H, Emoto N, Yokoyama M: Oral taurine supplementation prevents fructose-induced hypertension in rats. Heart Vessels, 2004, 19, 132-136. (Pubitemid 38842525)
15. Huxtable RJ: Physiological actions of taurine. Physiol Rev, 1992, 72, 101-163.
16. Kendler BS: Supplemental conditionally essential nutrients in cardiovascular disease therapy. J Cardiovasc Nurs, 2006, 21, 9-16.
17. Kingston R, Kelly CJ, Murray P: The therapeutic role of taurine in ischaemia-reperfusion injury. Curr Pharm Des, 2004, 10, 2401-2410. (Pubitemid 38855045)
18. Li N, Sawamura M, Nara Y, Ikeda K, Yamori Y: Direct inhibitory effects of taurine on norepinephrine-induced contraction in mesenteric artery of stroke-prone spontaneously hypertensive rats. Adv Exp Med Biol, 1996, 403, 257-262. (Pubitemid 26365204)
19. Liu HY, Chi FL, Gao WY: Taurine modulates calcium influx under normal and ototoxic conditions in isolated cochlear spiral ganglion neurons. Pharmacol Rep, 2008, 60, 508-513.
20. Militante JD, Lombardini JB: Treatment of hypertension with oral taurine: experimental and clinical studies. Amino Acids, 2002, 23, 381-393.
21. Moran J, Hernandez-Pech X, Merchant-Larios H, Pasantes-Morales H: Release of taurine in apoptotic cerebellar granule neurons in culture. Pflugers Arch, 2000, 439, 271-277.
22. Mozaffari MS, Patel C, Abdelsayed R, Schaffer SW: Accelerated NaCl-induced hypertension in taurine-deficient rat: role of renal function. Kidney Int, 2006, 70, 329-337. (Pubitemid 44086582)
23. Nakaya Y, Minami A, Harada N, Sakamoto S, Niwa Y, Ohnaka M: Taurine improves insulin sensitivity in the Otsuka Long-Evans Tokushima Fatty rat, a model of spontaneous type 2 diabetes. Am J Clin Nutr, 2000, 71, 54-58. (Pubitemid 30033584)
24. Nara Y, Yamori Y and Lovenberg W: Effect of dietary taurine on blood pressure in spontaneously hypertensive rats. Biochem Pharmacol, 1978, 27, 2689-2692.
25. Niu LG, Zhang MS, Liu Y, Xue WX, Liu DB, Zhang J, Liang YQ: Vasorelaxant effect of taurine is diminished by tetraethylammonium in rat isolated arteries. Eur J Pharmacol, 2008, 580, 169-174.
26. 2+ sequestration by taurine. Biochem Pharmacol, 1999, 58, 1123-1131. (Pubitemid 29381513)
27. Parildar-KarpuzoCrossed d signlu H, Mehmetçik G, Özdemirler-Erata G, DoCrossed d signru-AbbasoCrossed d signlu S, Koçak-Toker N, Uysal M: Effect of taurine treatment on pro-oxidant-antioxidant balance in livers and brains of old rats. Pharmacol Rep, 2008, 60, 673-678.
28. Schaffer S, Takahashi K, Azuma J: Role of osmoregulation in the actions of taurine. Amino Acids, 2000, 19, 527-546.
29. + currents in smooth muscle cells from rat resistance-sized cerebral arteries. Am J Physiol, 1993, 265, C1363-1370.
30. Ristori MT, Verdetti J: Effects of taurine on rat aorta in vitro. Fundam Clin Pharmacol, 1991, 5, 245-258.
31. Satake N, Shibata M, Sbibata S: The inhibitory effects of iberiotoxin and 4-aminopyridine on the relaxation induced by beta 1- and beta 2-adrenoceptor activation in rat aortic rings. Br J Pharmacol, 1996, 119, 505-510. (Pubitemid 26335312)
32. Schaffer S, Solodushko V, Pastukh V, Ricci C, Azuma J: Possible cause of taurine-deficient cardiomyopathy: potentiation of angiotensin II action. J Cardiovasc Pharmacol, 2003, 41, 751-759. (Pubitemid 36523178)
33. Sobey CG: Potassium channel function in vascular disease. Arterioscler Thromb Vasc Biol, 2001, 21, 28-38. (Pubitemid 32061924)
34. Song D, O'Regan MH, Phillis JW: Mechanisms of amino acid release from the isolated anoxic/reperfused rat heart. Eur J Pharmacol, 1998, 351, 313-322. (Pubitemid 28321467)
35. + channel modulation in arterial smooth muscle. Acta Physiol Scand, 1998, 164, 549-557. (Pubitemid 29015673)
36. Vieira TH, Moura PC Jr., Vieira SR, Moura PR, Silva NC, Wafae GC, Ruiz CR, Wafae N: Anatomical indicators of dominance between the coronary arteries in swine. Morphologie, 2008, 92, 3-6.
37. Xue WX, Zhang MS, Li J, Wu DM, Niu LG, Liang YQ: Effects of taurine on aortic rings isolated from fructose-fed insulin resistance and normal rat aortic rings are different. Cardiovasc Drug Ther, 2008, 22, 461-468.
38. Xue WX, Zhang MS, Niu LG, Liu Y, Liang YQ: Vasodilation effects and mechanism of taurine on rat thoracic aortas. Chin J Pharmacol Toxicol, 2007, 21, 23-27.
39. Zhang MS, Zhou EF: Methylflavonolamine hydrochloride inhibits contractions induced by noradrenaline, calcium and potassium in rabbit isolated aortic strips. Br J Pharmacol, 1988, 94, 1184-1188.